DEF 14AThe Ballot
Travere Therapeutics, Inc. files DEF 14A
Filed Apr 4, 2019 · 7y ago · Accession 0001193125-19-097950
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- DEF 14A
- Filing date
- Apr 4, 2019
- Report date
- May 8, 2019
- Document
- d663085ddef14a.htm
- Size
- 804 KB